Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Arthritis, Rheumatoid × Methotrexate × Clear all

Phase

Status

Sponsor Class

INDUSTRY 9 OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 157 Leukemia 114 Lymphoma 80 Leukemia, Myeloid, Acute 72 Myelodysplastic Syndromes 57 Burkitt Lymphoma 52 Lymphoma, Non-Hodgkin 45 Lymphoma, Large B-Cell, Diffuse 36 Lymphoma, Mantle-Cell 34 Graft vs Host Disease 34 Leukemia, Myeloid, Accelerated Phase 32 Leukemia, Lymphocytic, Chronic, B-Cell 32 Hodgkin Disease 32 Breast Neoplasms 29 Blast Crisis 29 Multiple Myeloma 28 Lymphoma, Follicular 28 Recurrence 27 Leukemia, Myeloid, Chronic-Phase 27 Congenital Abnormalities 26 Myeloproliferative Disorders 25 Leukemia, Myelomonocytic, Chronic 25 Lymphoma, Large-Cell, Immunoblastic 22 Primary Myelofibrosis 21 Lymphoma, B-Cell, Marginal Zone 21 Osteosarcoma 19 Neoplasms, Plasma Cell 19 Hematologic Neoplasms 19 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 18 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 17

Interventions

Etanercept 12 Adalimumab 11 Infliximab 7 golimumab 4 Certolizumab Pegol 4 Tumor Necrosis Factor Inhibitors 3 Abatacept 3 tofacitinib 2 tocilizumab 2 Vitamin D 1 Vaccines 1 Syringes 1 Surveys and Questionnaires 1 Standard of Care 1 Saline Solution 1 Rituximab 1 Radioimmunodetection 1 Prednisone 1 Practice Guidelines as Topic 1 Phlebotomy 1 Observation 1 Nivolumab 1 Methotrexate 1 Methods 1 Lysine Acetyltransferase 5 1 Licensure 1 Leflunomide 1 Interviews as Topic 1 Holistic Health 1 High-Intensity Interval Training 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03589833 2022-10-25

YISTAR

Peking Union Medical College Hospital

Phase 4 Completed

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡